Showing results (2021-2030 of 2,286) with videos related to
Sort By:
Pageof 229
Preventive Veterinary Medicine|July 18, 2021
Optimizing surveillance for early disease detection: Expert guidance for Ostreid herpesvirus surveillance design and system sensitivity calculationLori L Gustafson, Isabelle Arzul, Colleen A Burge, et al.Neuro-Oncology|March 10, 2007
Temozolomide in children with progressive low-grade gliomaSridharan Gururangan, Michael J Fisher, Jeffrey C Allen, et al.Cancer|June 19, 2014
Oncolytic polio virotherapy of cancerMichael C Brown, Elena Y Dobrikova, Mikhail I Dobrikov, et al.Journal of Glaucoma|January 10, 2025
Glaucoma Screening and Referral Risk Factors in a High-Risk Population: Follow-Up Study of the Manhattan Vision Screening StudyQing Wang, Ives A Valenzuela, Noga Harizman, et al.Cell Reports|December 14, 2022
Stable isotope tracing in vivo reveals a metabolic bridge linking the microbiota to host histone acetylationPeder J Lund, Leah A Gates, Marylene Leboeuf, et al.NIH Consensus and State-Of-The-Science Statements|February 9, 2010
NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screeningDonald Steinwachs, Jennifer Dacey Allen, William Eric Barlow, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.Medical and Pediatric Oncology|December 24, 1997
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomasG B McCowage, H S Friedman, A Moghrabi, et al.Pageof 229